News

Most of diabetic foot are gram positive bacteria

2012-07-13

Liu Jianfeng from Guangzhou Red Cross Hospital published a paper, by analysis 87 strains of pathogenic bacteria and MTT colorimetric assay trends that separated from exudate of 69 patients’ diabetic foot merging ulcer surface, that were received and cured by this hospital from January of 2003 to December of 2010, the results indicates that gram positive bacteria is the majority of pathogenic bacteria that infected diabetic foot ulcer, and the drug-resistant situation is severe. It is necessary to strengthen bacilli culture and MTT colorimetric assay check of diabetic foot ulcer exudate, and to use antibiotics appropriately, so as to improve cure efficiency and improve patients’ prognosis.

Previous article

WTO release the first Global Antibiotics Resistant Report

Next article

Talking about antimicrobial peptide

/news_detail/49.html

■

ProteLight Pharma’s Innovative Antimicrobial Peptide PL-18 Suppository Has Received FDA Approval to Commence Clinical Studies.

—

2024-10-26

■

ProteLight Pharma’s Innovative Antimicrobial Peptide PL-18 Suppository Has Received FDA Approval to Commence Clinical Studies.

■

ProteLight Pharma’s Innovative Antimicrobial Peptide PL-3301 Oral Gel Has Been Granted FDA Approval To Commence Clinical Trials.

■

The publication of a confirmative Phase III clinical study on Peceleganan Spray (project code: PL-5), an innovative antimicrobial peptide developed by ProteLight Pharms, has been released.

■

ProteLight Pharma was selected into the list of “Top 100 Chinese Pharmaceutical Innovative Seed Enterprises in 2023”

■

Congratulations to the company for passing the ISO9001 quality management system certification

■

Antimicrobial Peptide PL-18 Suppository (First-in-class new drug) of ProteLight Pharma Received Clinical Trial Approval from CDE in China